[Nitric oxide: physiological and pathophysiological properties].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N A Vinogradov.
Explore the source record for details and available documents.
The end products of nitric oxide (NO) metabolism in human organism, i.e. anions, nitrites (NO2) and nitrates (NO3), are excreted predominantly (95%) via urine. The quantity of these products in urine is an adequate index of NO synthesis in human organism. We measured the quantities of of NO2 and NO3 excreted during of monoviral hepatitis A, B, C, D and in the course of mixed viral hepatic infections, which were caused by the above mentioned viruses. The hyperexcretion of NO2 and NO3 was higher and longer during hepatitis C and D versus hepatitis B, and during the latter versus hepatitis A. The inability of NO to stop the infection may be caused by low sensitivity of the viruses to NO and/or by local low concentration of NO in the site of inflammation.
We examined 170 patients with acute viral hepatitis B (AVH-B) and 10 patients with chronic hepatitis B (CH-B) exacerbation. 85% of them were under 40 years old. During the 12-hour night period we measured urine excretion of nitrites (NO2-) and nitrates (NO3-). It was significantly high in AVH-B but in CH-B exacerbation it did not differ from the controls. ACTH and hydrocortisone blood levels were significantly high in AVH-B and in CH-B exacerbation. Though hydrocortisonemia and nitrituria/nitraturia during AVH-B were both high, the correlation between them was negative due to nitric oxide (NO) synthesis suppression by hydrocortisone. A negative correlation between nitrituria/nitraturia and ALAT, ASAT, bilirubin, alkaline phosphatase, gamma-glutamyl-transpeptidase is an indirect evidence for a protective role of NO against viral hepatitis B.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Forty five patients at the age of 15 to 84 years with signs of infection requiring active antibacterial therapy were treated with cefotetan. In the majority of the patients pulmonary affections such as double pneumonia, pleurisy or bronchopneumonia were stated. In some patients bronchopulmonary pathological processes were associated with pancreatitis, cholecystitis or other diseases of the gastrointestinal tract. A separate group included patients with diseases of the small pelvis organs (pelvioperitonitis, metroendometritis or prostatitis) and diseases of the urogenital system (pyelonephritis) arachnoiditis. In all the patients except for one with bronchopneumonia at the background of chronic myeloleukemia and agranulocytosis the results of the treatment were good and satisfactory. Cefotetan proved to be efficient in the treatment of purulent affections of the skin and subcutaneous fat (abscesses and phlegmona), trophic disturbances at the background of pathological processes in the vessels and pyoseptic condition. Cefotetan practically had no side effects. Only in 2 patients insignificant nausea during the first 2 days of the treatment was recorded. In some patients the antibiotic intramuscular injections were painful with formation of cold infiltrates. After intravenous administration of cefotetan no adverse reactions were observed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In this article information on an important role of nitric oxide (NO) in inhibiting the growth of a number of pathogenic microorganisms, including intracellular parasites, and their elimination from the host body is presented. Differences between the mechanisms of the production of NO and free-radical compounds having antimicrobial action are given. The regulation of the activity of constitutive NO-synthase and inducible NO-synthase and the relationship between the latter and the phagocytic activity and production of anti-inflammatory cytokines are described. An important role of NO in the development of the nonspecific resistance of the body is mentioned.
During the study of 186 K. pneumoniae clinical strains the presence of SIgA-protease activity was detected in 109 isolates (58.6%). The PCR test system permitting the detection of iga gene DNA in K. pneumoniae strains isolated in purulent inflammatory processes of different localization was developed. For the first time a conjugative plasmid with a mol. wt. of 100 MD was detected in K. pneumoniae clinical isolates. This plasmid controlled the capacity of inactivating SIgA, carried the markers of antibiotic resistance and was capable of expression in a wide circle of hosts belonging to the family Enterobacteriaceae. The results of in vitro experiments revealed that the strains containing plasmid SIgA were cytotoxic with respect to cells HEp-2 and more resistant to the digestive action of enzymes produced by the phagolysosomes of guinea pig peritoneal cells. As shown on the in vivo biological model with the use of the genetically linked pair of Salmonella typhimurium 274 vaccine strains, differing in SIgA-protease activity, plasmid pSigA ensured more prolonged survival of bacteria in mice in comparison with the nonplasmid variant. The study of SIgA-protease activity of K. pneumoniae strains circulating among patients with a view to the detection of clones causing the development of persistent infection was shown to have good prospects.